Sol Gel Technologies Ltd
NASDAQ:SLGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
RVRC Holding AB
STO:RVRC
|
SE |
|
S
|
Shougang Fushan Resources Group Ltd
HKEX:639
|
HK |
|
D
|
Danlaw Technologies India Ltd
BSE:532329
|
IN |
Sol Gel Technologies Ltd
EPS (Diluted)
Sol Gel Technologies Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
EPS (Diluted)
-$2
|
CAGR 3-Years
30%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
EPS (Diluted)
$1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
EPS (Diluted)
-$2
|
CAGR 3-Years
67%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
EPS (Diluted)
-$2
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
S
|
Seach Medical Group Ltd
TASE:SEMG
|
EPS (Diluted)
₪0
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
EPS (Diluted)
-₪1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
Sol Gel Technologies Ltd
Glance View
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
See Also
What is Sol Gel Technologies Ltd's EPS (Diluted)?
EPS (Diluted)
-2.2
USD
Based on the financial report for Dec 31, 2025, Sol Gel Technologies Ltd's EPS (Diluted) amounts to -2.2 USD.
What is Sol Gel Technologies Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
30%
Over the last year, the EPS (Diluted) growth was 42%. The average annual EPS (Diluted) growth rates for Sol Gel Technologies Ltd have been 30% over the past three years , 30% over the past five years .
